Home › News › Pharma Industry News › Archive

Pharmaceutical Industry News Archive

Get news By email or subscribe to our News feeds.

All News Consumer Pharma New Drugs Pipeline Clinical Trials

April 2007

April 2

FDA Approves Janumet for Type 2 Diabetes, Offering Powerful Glucose Control of a DPP-4 Inhibitor and Metformin in a Single Tablet Baxter Announces FDA Approval Of Ceprotin For Severe Congential Protein C Deficiency Interpublic to Participate in J&J Media Review Novartis Suspends Canadian Marketing and Sales of Zelnorm in Response to Request From Health Canada Roche Acquires THP in $56.5 Million Deal INEX Extends Timeline for Completing Spin-out of Tekmira Pharmaceuticals Corporation Abbott Seeks U.S. and E.U. Regulatory Approval for Humira (Adalimumab) in Psoriasis IMPAX Settles Oxycontin Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals NeoPharm Provides Update on LE-SN38 Program Cephalon Provides Update Related to Nuvigil New Drug Application Auriga Laboratories Expects Q1 2007 Gross Revenue to Exceed a Record $8 Million EPIX Provides Update Regarding Status of Vasovist Appeal Boehringer Ingelheim: Media Statement The Transfer of All Commercial Rights for Panaldine FDA Approves Rhophylac for the Treatment of Immune Thrombocytopenic Purpura (ITP) GlaxoSmithKline K.K. Seeks Approval in Japan for Lapatinib, a New Treatment for Breast Cancer FDA Approves Accelerated Dosing Schedule for GlaxoSmithKline's Twinrix Large Study Shows that Presence of Neutralizing Antibodies Did Not Predict Clinical Response to Betaseron Treatment Genencor's Technology for Production of Secreted Polypeptides Licensed by Pfizer Pharmaceutical Federal Lobbying Spending Flourishes PerkinElmer Acquires Improvision Ltd. Sun Pharma Announces Approval of Demerger by High Court and Fixing of Record Date 30 April 2007 Fitzpatrick Cella Wins Appeal on Behalf of Merck & Co. in Trusopt Patent-Infringement Case Pharmacia Subsidiaries Reach $34.7 Million Settlement with DOJ; Resolve Allegations of Improper Activities Prior to Acquisition by Pfizer Publicis Groupe to Expand Further in China: Acquires Majority Stake in Yong Yang, Leading Marketing Services Group Fitzpatrick Cella Wins Appeal on Behalf of Merck & Co. in Trusopt Patent-Infringement Case

April 3

Once Daily, Extended-Release Ropinirole Improves Parkinson's Symptoms in Patients not Optimally Controlled With Levodopa Beijing Med-Pharm Corporation and Alliance Boots plc Joint Venture Acquisition Plans Approved by Guangzhou Pharmaceuticals Company Ltd. Shareholders AmerisourceBergen to Acquire Xcenda LLC Codexis and Merck Sign Technology Collaboration New Data Show Early Non-Response to Antipsychotic Treatment May Be Strong Predictor of Subsequent Non-Response for People with Schizophrenia Nipent Acquisition by Hospira is Complete Wyeth Completes Purchase of Wyeth K.K. Japan MediVas Announces Achievement of Milestone in Connection With Merck Agreement New Data Confirm That Use of Levemir Can Limit Weight Gain Fewer Children and Teens Received Antidepressants Following FDA Warnings Bristol-Myers Squibb Gets Civil Investigative Demand From FTC Boston Scientific Announces Japanese Approval for the Taxus Express2 Stent System Lilly Announces Completion of Hypnion Acquisition Crucell Announces European Protein Distribution Deal with Talecris Biotherapeutics Managing Diabetes is Now Simpler and More Convenient with New Premixed Insulin Analogue

April 4

Innocoll Receives FDA Approval to Commence Phase 2 Clinical Development with its CollaRx Bupivacaine Implant for the Management of Post-operative Pain Cerimon Pharmaceuticals Initiates ARREST UC-1, a Global Phase 2b Study of Basiliximab in Patients with Steroid-Refractory Ulcerative Colitis Applied DNA Sciences Acquires Applied DNA Sciences Europe Ltd. Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer Lux Biosciences Initiates Clinical Trials of Its Second Pivotal Stage Program Effect of Hormone Therapy on Risk of Heart Disease May Vary by Age and Years Since Menopause Britain's OFT Launches Market Study Into UK Medicines Distribution Icagen Terminates Phase III ASSERT Study New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy Study Suggests Some Drug Resistance to Influenza B Medications Combination Treatment for Migraine More Effective Than Single Medications pSivida Signs $165 Million(US) Collaborative Research and Licensing Agreement with Pfizer Genzyme Files for Expanded Label for Campath as First-Line Treatment For B-CLL Patients Merrimack Pharmaceuticals Initiates Enrollment in a Phase 2 Pilot Study of MM-093 in Patients with Autoimmune Uveitis Manhattan Pharmaceuticals Announces License Agreement and Expanded Pipeline Marshall Edwards, Inc. Renegotiates Annual License Payments for Phenoxodiol AVEO Enters into Worldwide License and Development Agreement with Schering- Plough for AV-299, AVEO's Novel Anti-HGF Antibody Metabasis Therapeutics Initiates a Proof of Concept Study for MB07803, Its Second Product Candidate for the Treatment of Type 2 Diabetes Genta Appeals FDA Decision on Genasense in CLL Pharmacyclics' Xcytrin New Drug Application for Treatment of Lung Cancer Brain Metastases to Be Filed Over Protest Bayer Healthcare Pharmaceuticals Officially Launches in the United States Shionogi Announces Revisions to the Second Medium-Term Business Plan Shionogi & Co., Ltd. - Notice of Revision of Results Forecast for the Year Ended March 31, 2007 Roche to Acquire BioVeris for $21.50 Per Share Roche to Acquire Bioveris to Expand Its Leading ECL Immunochemistry Business Into New Market Segments Meditrina Pharmaceuticals, Inc. Initiates Phase II Trial and Raises $4.4M in Initial Funding DOR BioPharma Announces Initiation of Clinical Development Program for Oral Leuprolide Biopure Announces CEO's Prepared Remarks at Annual Meeting of Stockholders Crucell Announces Start of Rabies Phase I Antibody Cocktail Clinical Study in India four months after launching initial US Trial New Report: Allowing the Government to Negotiate Medicare Drug Prices Would Save Taxpayers $30b Annually Medifacts International Divests CRO Division Regulatory Approval to Start Pediatric Clinical Trials for Japanese Encephalitis (JE) Vaccine in India Obtained

April 6

ARIAD Provides Update Regarding AP23573 Phase 3 Trial in Metastatic Sarcoma VaxGen to Receive $11M, Release From Potential Liabilities Under Settlement Agreement with U.S. Government; Conference Call Scheduled for Today MediMedia USA Acquires Majority Interest in Complete Healthcare Communications, Inc. (CHC) Treatment-Induced Growth Factor Causes Cancer Progression Sen. Grassley Seeks Marketing and Safety Documents from Major Drug Maker Statins Linked to Lower Risk of Infection Childhood Immunization Against Pneumonia Cuts Hospital Admissions by Almost 40% Barr Confirms Patent Challenge of Ambien CR FDA approves Cangene's HepaGam B for a Second Indication; for Use in Hepatitis B-positive Liver Transplant Recipients Abbott Announces FDA Approval of a New Coated Niaspan Tablet Wyeth Provides Update on FDA Review of the Torisel New Drug Application FDA MedWatch Announces Tigan (trimethobenzamide hydrochloride) - Product Market Withdrawal Due to Lack of Evidence of Effectiveness

April 10

GSK and Adolor Announce Preliminary Results from Phase 3 Safety Study of Alvimopan (Entereg/Entrareg) Public Citizen Calls on FDA to Stop Illegal Celebrex Television Advertisement Media Advisory: Voluntary Drug Recall - Ortho-McNeil Pharmaceutical, Inc. Issues a Nationwide Recall of Grifulvin V/Griseofulvin Oral Suspension Abbott Agrees With World Health Organization (WHO) Director-General to Expand Access to Kaletra/Aluvia (lopinavir/ritonavir) Mylan Increases Fiscal 2007 Adjusted Diluted EPS Guidance to $1.60 - $1.63 Excluding Any Contribution from the Recent Launch of Amlodipine Besylate Boehringer Ingelheim Expands GeneGo Licenses to Global Agreement FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc. Abbott Opens New Biotechnology Manufacturing Facility in Puerto Rico Pfizer and Renovis Extend Research Collaboration to Identify Small Molecule VR1 Antagonists Information Policy Institute Finds Restrictions on Provider-Identifiable Healthcare Data Are Anti-Competitive and Will Not Lower Drug Prices Cardinal Health Completes Sale of Pharmaceutical Technologies and Services Segment to The Blackstone Group Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer FDA Announces Important Notice About Combivir and Ziagen Galapagos Issues 628,058 New Shares Related to Inpharmatica Acquisition and Warrant Exercise U.S. District Court Grants Extension for Consideration of Amlodipine Besylate Exclusivity

April 11

Neurochem's Eprodisate (Kiacta) PDUFA Date Extended Three Months by FDA Statement by Merck & Co., Inc. Regarding FDA Arthritis Drugs Advisory Committee Meeting on Arcoxia (etoricoxib) Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C Transgene and Roche Enter Partnership on Therapeutic Vaccines Against HPV-Mediated Diseases Illumina Announces Consolidation of Connecticut Operations inVentiv Health Announces the Consolidation and Strengthening of its Sampling and Regulatory Compliance Offerings Pro-Pharmaceuticals Receives Letter from the FDA for New Drug Application for Davanat/ 5-FU Genaera Corporation Completes Strategic Review and Announces Plan to Focus Resources on Obesity and Asthma Programs District Court Calls for GlaxoSmithKline to Release Bond Amount of $3 Million to Roxane Laboratories Relating to the Launch of Generic Fluticasone Propionate Phenomenex, Global Leader in Separation Sciences Technology, Announces Acquisition of Two Companies in Italy and Denmark Publicis Groupe Acquires The McGinn Group, Bolstering Manning Selvage & Lee's Strengths inCorporate Communications Ranbaxy Receives Approval To Market Cefprozil Tablets and Cefprozil Powder For Oral Suspension in Canada Interpublic Acquires Best-in-Class Search Marketing Agency Third Point Demands that PDLI CEO Mark McDade be Terminated or Resign; Insists that Company Pursue Cost Cutting Measures and Consider Alternatives to Maximize Shareholder Value

April 12

Genentech Announces First Quarter 2007 Results Array BioPharma Achieves Milestone for Dosing MEK Inhibitor, ARRY-704, in Phase 1 Clinical Trial Indevus and Valera Announce Merger Exchange Ratio Coley Pharmaceutical Group Licenses VaxImmune(TM) to Merck for Use in Vaccine Programs MedImmune Explores Strategic Alternatives Zanaflex (tizanidine hydrochloride) Tablets and Capsules - Changes to the Contraindications and Warnings Sections of the Approved Product Labeling U.S. Federal Circuit Court Affirms Judgment for Allergan, Inc. and Roche Palo Alto, LLC against Apotex, Inc., Apotex Corp., and Novex Pharma in Ketorolac Patent Infringement Lawsuit GSK Initiates REPEAT Dosing Study of Its Novel Oral Platelet Growth Factor, Promacta, in ITP A Genetic 'Gang of 4' Drives Spread of Breast Cancer Lupin Receives US FDA Approval for Novel Formulation of Suprax Suspension Chromos Plans to Restructure Virax to Receive Milestone Payment from Transgene through Co-X-Gene Technology Licence

April 13

GSK Announces FDA Approval of Altabax (Retapamulin Ointment), 1% FDA Advisory Committee Recommends Against Approval for Merck's NDA for Arcoxia (etoricoxib) Merck Anticipates Higher Than Expected First-Quarter Results; Raises Full-Year 2007 Earnings Per Share Guidance FDA to Hold Public Hearing on Medication Guide Program CDC Changes Recommendations for Gonorrhea Treatment Due to Drug Resistance pSivida Sells AION Diagnostics Subsidiary National Kidney Foundation Releases Preliminary Anemia Guideline Update Baraclude (entecavir) Therapy Resulted in Undetectable Levels of Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment Eisai Withdraws Application for Additional Indication of Aricept for Treatment of Severe Alzheimer's Disease in Europe Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275 Avista Capital Partners Completes Acquisition of BioReliance Corporation from Invitrogen Corporation Federal Court Dismisses Vioxx Securities Class Action FDA Approves New Dose of Risperdal Consta for Schizophrenia Treatment Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study Invitrogen Completes Divestiture of BioReliance

April 16

Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales and EPS Guidance Cytochroma and Genzyme Settle Lawsuit Ariad Files Claim Against Amgen and Wyeth Alleging Infringement of NF-(kappa)B Patent by Enbrel and Kineret FDA Accepts GPC Biotech's Satraplatin NDA for Filing and Grants Priority Review Status Avant Restructures Organization to Focus Resources on Core Programs and Operations Interim Results Presented at EASL from PROVE 1 Clinical Trial of Investigational Drug Telaprevir in Patients with Genotype 1 Hepatitis C U.S. Government Notifies Bavarian Nordic of Intent to Acquire 20 Million Doses of Imvamune Smallpox Vaccine Boston Scientific Resolves CRM Warning Letter Deficiencies Results of Extraordinary General Meeting held on 16 April 2007 Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting

April 17

Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration Enters Development Reclast Receives US Approval as a Highly Effective Treatment for Patients with Paget's Disease of the Bone VioQuest Pharmaceuticals Signs Definitive Agreement for Sale Valued Up to $3 Million of Chiral Quest Subsidiary Johnson & Johnson Reports 2007 First-Quarter Results: Sales Increase of 15.7% and EPS of $.88 Versus $1.10 a Year Ago; Excluding Special Items, EPS was $1.16, an increase of 17.2% * Cegedim SA's Proposed Acquisition of Dendrite International, Inc. Clears U.S. Antitrust Review FDA Approves New Actonel Dose to Treat and Prevent Postmenopausal Osteoporosis Merck Submits New Cross-Protection Data for Gardasil to the FDA and Seeks New Indications for Vaginal and Vulvar Cancers Eisai Announces Completion of Acquisition of Morphotek Catalina Marketing Agrees to be Acquired by Hellman & Friedman for $32.50 Per Share in Cash FDA Licenses First U.S. Vaccine for Humans Against Avian Influenza Warner Chilcott Announces Settlements in Principle of Antitrust Suits Brought by States and Indirect Purchasers Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100 Percent Protection Against Precancerous Lesions Caused By Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than Five Years GE Healthcare Acquires Wave Biotech LLC, Broadening Capabilities in Growing Biopharmaceutical Manufacture Segment Patheon Announces Plans to Restructure Canadian Site Network FDA Approves First U.S. Vaccine for Humans Against the Avian Influenza Virus H5N1

April 18

Abbott Reports 15.5 Percent Sales Growth in First Quarter MCF Corporation Closes on the MedPanel, Inc. Transaction Anemia Treatment for Patients with Kidney Disease Can Differ by Dialysis Facility Type Benefits of Antidepressants Appear Greater Than Risks for Children, Teens Cortex's AMPAKINE CX717 Toxicology Data Package Submitted to FDA Health Industry Insights Identifies Pharmaceutical Industry's Top Roadblocks to RFID Adoption Roche Posts Strong First Quarter Sales – Upgrade of Core Earnings Per Share Outlook for 2007 Breakthrough Cancer Drug Avastin Approved in Japan for Use in Advanced or Recurrent Colorectal Cancer Phoenix Marketing International's Health Care Practice Quantifies Consumer Confidence in Pharmaceutical and Medical Websites INC Research Expands Therapeutic Focus with Infectious Disease Capabilities Cell Therapeutics, Inc. to Pay United States $10.5 Million to Resolve Claims for Illegal Marketing of Cancer Drug CTI Settles Qui Tam Suit with Government, Suit Against Medicare Reimbursement Advisor to Recover Damages Filed S&P: Fourth Annual "Top 10 Pharma Products To Watch" Report Published Large Numbers of People Are Not Very Confident in Their Own Knowledge and the Safety of Prescription Medications and This Often Leads to Non-Adherence New Report Shows Prices for Top Medicare Part D Drugs Grew by 9.2 Percent in Past Year New Study Reveals Generic Drugs Continue Entering Market as Authorized Generic Competition Increases Entelos Acquires SPRM Compound Series Med Ad News Honors Health-Care Advertisers at 18th Annual Manny Awards

April 19

Baxter Reports Strong First Quarter Financial Results and Boosts Full-Year Outlook Wyeth Reports Earnings Results for the 2007 First Quarter Wyeth Responds to Special Report Published in New England Journal of Medicine Schering-Plough Reports Financial Results for First Quarter of 2007 Neurochem Update on the North American Phase III Clinical Trial for Tramiprosate (ALZHEMED) for the Treatment of Alzheimer's Disease Schering-Plough Announces Initiation of Two Phase III Clinical Trials for Novel Selective Antiplatelet Therapy (TRA-SCH 530348) PhRMA Statement on Families USA Reports Schering-Plough Announces Zetia Approved in Japan for Treatment of High Cholesterol Antisoma Announces Global Agreement with Novartis for Cancer Drug AS1404 Gilead Sciences Announces First Quarter 2007 Financial Results Novartis Expands Late-stage Oncology Pipeline With AS1404, a Novel Agent Shown to Break Down Blood Vessels That Support Tumor Growth National Medical Association Seeks to Increase Diversity in Clinical Trials Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals Ovarian Cancer Deaths Due to HRT In UK Since 1991 NeoPharm, Inc. Announces Strategic Reassessment and Reorganization Merck Reports Strong Financial Results for First-Quarter 2007 Aranesp "145 Study" Shows No Difference in Survival in Patients with Small-Cell Lung Cancer First-of-its-Kind Email Newsletter Recaps the Issues Raised by Pharmaceutical Industry Bloggers BTG signs agreement with Novacea and KuDOS for AQ4N Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Breaks Ground on New Facility

April 23

Texas Court Dismisses Claim of Vioxx User Who Said Merck Failed to Properly Warn of the Alleged Risks KaloBios Licenses Humaneering Technology to Major Pharmaceutical Company CollaGenex Pharmaceuticals Provides Update on Examination of Incyclinide Patent Application AstraZeneca Announces Decision to Discontinue Collaboration With AtheroGenics Regarding AGI-1067 AstraZeneca PLC: First Quarter Results 2007 AstraZeneca to Acquire MedImmune For $58 Per Share in a Fully Recommended, All-cash Transaction with a Total Enterprise Value of $15.2 Billion Novartis with Dynamic Growth in the 2007 First Quarter FDA MedWatch: Avastin (bevacizumab) and Formation of Tracheoesophageal Fistula in a Recent Clinical Study in Patients with Limited-stage Small Cell Lung Cancer Application for an Additional Indication of CombinationTherapy of Glufast® and Insulin Sensitizer in Japan Many Americans Deeply Skeptical Of Pharmaceutical Companies-- Motives For Supporting Non-Profits Synosia Therapeutics Announces Second Major Pharmaceutical Deal Actavis Completes Acquisition of Abrika Pharmaceuticals in the US The Westaim Corporation to Undertake Review of Business Strategy

April 24

Amgen's First Quarter 2007 Revenue Increased 15 Percent to $3.7 Billion Astex Grants Cytochrome P450 License to Glaxosmithkline FDA Approves Alpharma's Kadian New 10mg Strength FDA Approves First Generic Versions of Ambien (Zolpidem Tartrate) for the Treatment of Insomnia Forest Laboratories, Inc. Reports Fiscal Year 2007 Fourth Quarter Revenues of $885,000,000, Reported EPS Loss of ($0.75) and Adjusted EPS of $0.74*, Excluding the Effect of the Cerexa Acquisition MultiCell Signs License Agreement With Eisai Japan to Use Fa2N-4 Cell Line for Drug Discovery/ADMETOX Applications Drug Reps Use Friendship to Influence Doctors, Says Faculty Member China Aoxing Pharmaceutical Company Signs Letter of Intent to Acquire Shijiazhuang Le Ren Tang Pharmaceutical Ltd. Drug Company Sales Visits Influenced Doctors, Study Finds Acomplia (rimonabant) is Reimbursed in Switzerland for the Treatment of Type 2 Diabetics Overweight Patients and for the Treatment of Patients with Obesity SEC Charges Husband of Amgen Vice President with Insider Trading Akzo Nobel NV (NL) - Refocused Akzo Nobel reports strong first quarter results Elan Reports First Quarter 2007 Financial Results Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease SVB Silicon Valley Bank Provides $19 Million in Buyout Financing for Vector Capital's Acquisition of Tripos Dey, L.P. Reaches Settlement with Commonwealth of Massachusetts on Pricing Litigation Vernalis plc Announces Intent to Delist from The Nasdaq Stock Market and to Deregister and Terminate its U.S. Reporting Obligations under the Securities Exchange Act of 1934 Merck's Plan to Win Has Company Poised to Reclaim Position as Industry Leader, Chairman and CEO Tells Stockholders Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis

April 25

QLT Announces that CHMP Will Recommend to the European Commission that Occult Indication be Deleted from the Visudyne Label in European Union Shire plc: First Quarter Results - Strong Start to the Year With Upgraded Guidance Now Including New River FDA Advisory Committee Recommends Accelerated Approval of Pfizer's Maraviroc for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1 AmerisourceBergen Receives DEA Order to Temporarily Halt Distribution of Controlled Substances from Its Orlando, Florida Facility Biotech Drug Spending Increases 21 Percent Even as Growth in Rx Expenditure Slows QLT Announces Q1 Results for 2007 PhRMA Statement on Medicare Trustees Annual Report FDA Sends Alcon Warning Letter Over Ciprodex Literature Medtronic Responds to ''Inequitable Conduct'' Decision by U.S. District Court in Stent Litigation Novartis Expands Portfolio of Respiratory Medicines Dyadic Announces Discovery of Potentially Material Operational and Financial Improprieties at its Hong Kong and Mainland China Operations New Indication for Singulair (montelukast sodium) Approved to Prevent Exercise-induced Bronchoconstriction GlaxoSmithKline: Results Announcement for the First Quarter 2007 Q1/2007: Merck KGaA Total Revenues Grow 37% to EUR 2.2 Billion Journal of the American Medical Association Publishes MERLIN TIMI-36 Results New Data Supports Safety of Anti-anginal Drug but Not Its Effectiveness in Reducing Recurrent Major Cardiac Events in Patients with Acute Coronary Syndromes Orion's Partner Discontinues Development of Levosimendan (Simdax) in the US Genzyme Reports Significant Revenue and Earnings Growth in First Quarter New Trial Expands Evidence for Glucobay in Prevention of Cardiovascular Diseases FDA Approves Labeling Update for Orencia (abatacept) to Inhibit Structural Joint Damage in Adults with Moderate to Severe Rheumatoid Arthritis Health Canada Approves Lipitor for the Reduction of the Risk of Heart Attack in Patients with Coronary Heart Disease Large Numbers of People Do Not Trust the Institutions They Identify as Most Responsible for Drug Safety Questions Over Zyprexa Clinical Trial Data Underscore Need for Congress to Act Now on Drug Safety Legislation Roche Carolina Inc. to Expand Manufacturing at Florence Facility Solvay Pharmaceuticals Files Tedisamil, a New Cardiometabolic Product for the Treatment of Atrial Fibrillation and Atrial Flutter Kirin's NESP Long-Acting Erythropoiesis Stimulating Agent Injection Syringe Receives Approval in Japan BioLife Solutions Grants Product License to Centocor Research & Development, Inc.

April 26

Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds Pfizer Subsidiary Pleads Guilty to Kickback Violation and Is Sentenced to Pay Criminal Fine of $19.68 Million James M. Cornelius Elected Bristol-Myers Squibb CEO Roche Update on Tamiflu for Pandemic Influenza Preparedness ImClone Systems Reports First Quarter 2007 Financial Results Bayer Exceeds Consensus Estimates for the First Quarter of 2007 Physician Ties to Drug Industry Stronger Than Ever New Finance Committee Report Focuses on Drug Company Grants for Medical Education Bristol-Myers Squibb Company Reports First Quarter 2007 Financial Results Bristol-Myers Squibb Company Reports First Quarter 2007 Financial Results Phoenix Marketing International's Health Care Practice Quantifies Visitor Confidence in Pharmaceutical Websites Cerus to Explore Strategic Alternatives for Its Immunotherapy Programs Acomplia (rimonabant) is Approved in Brazil for the Treatment of Obese Patients, or Overweight Patients with Associated Risk Factors, Such as Type 2 Diabetes or Dyslipidemia Pfizer Focused on Delivering the Value Customers Expect and Shareholders Deserve, CEO Kindler Tells Shareholders The New ALTANA Starts with Good First Quarter 2007

April 27

Abbott's Humira (Adalimumab) Receives Positive Opinion from European Medicines Agency for the Treatment of Crohn's Disease Invega Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia Hollis-Eden Pharmaceuticals Announces Reorganization ArQule and Kyowa Hakko Kogyo Sign Exclusive License Agreement in Asia for ARQ 197, c-Met Inhibitor FDA Sends Warning Letter to DUSA Pharmaceuticals Over Actinic Keratosis Treatment Ad Cipher Pharmaceuticals Receives Approvable Letter from FDA for CIP-ISOTRETINOIN Kyowa Hakko Fiscal 2006 Operating Income up 20.2% Submission of NDA for Istradefylline(KW-6002), an Investigational Anti-Parkinson's Disease Drug Pharmasset Prices Initial Public Offering Inex Pharmaceuticals Announces Expected Completion Date for Spin-out of Tekmira Pharmaceuticals Corporation EMEA Issues 15 Opinions Wyeth Chief Financial Officer and Vice Chairman Kenneth J. Martin to Leave the Company Merck Receives Non Approvable Letter from FDA for Arcoxia (etoricoxib) Schering-Plough Announces EU Approval Of Two New Formulations Of Aerius (Desloratadine) Werner Wenning at the Annual Stockholders’ Meeting in Cologne: Bayer Off to an Excellent Start in 2007 Blogs Scrutinize Relationships Between Physicians and Pharmaceutical Sales Reps, Drug Companies and Non-Profits Merck Receives Non Approvable Letter from FDA for Arcoxia (etoricoxib) Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study FDA Approves Invega for Long-Term Maintenance Treatment of Schizophrenia Abbott Reviews 2006 Accomplishments at Annual Shareholders' Meeting Ark Therapeutics Group Announces EMEA Decision on Cerepro Phase II Filing

April 30

InSite Vision Announces FDA Approval for AzaSite Approval Triggers $19 Million Milestone Payment Sangamo BioSciences Announces Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production FDA Approves Product to Treat Common Bleeding Disorder Newly Published Study Reveals Femara Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women Sebivo (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients GlaxoSmithKline and Wellcome Trust Announce Partnership to Target Drug-Resistant Hospital Infections FDA Approves Lantus SoloStar - A New Prefilled Disposable Insulin Pen For Use With Lantus In People With Type 1 And Type 2 Diabetes Duramed's Enjuvia (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals Court Grants Hemosol Further Stay Extension Sebivo Approved in European Union as a New First-line Treatment for Chronic Hepatitis B Cardiome Announces In-Licensing Agreement With Eli Lilly and Company Humate-P Approved to Prevent Excessive Bleeding in Patients with von Willebrand Disease Undergoing Surgery Mylan Remains the Only Approved ANDA for All Strengths of Amlodipine Besylate Tablets

Pharmaceutical Industry News Archive

More News Resources

Printable Version Email Recommend Tweet Save or Share
(web1)